ストックスクリーナーアプリを入手
0.5262
2.56%
-0.0138
アフターアワーズ：
.53
0.0038
+0.72%
前日終値:
$0.54
開ける：
$0.54
24時間の取引高:
215.86K
Relative Volume:
0.43
時価総額：
$28.10M
収益：
-
当期純損益:
$-151.16M
株価収益率:
-0.1772
EPS:
-2.97
ネットキャッシュフロー:
$-130.08M
1週間 パフォーマンス:
+3.87%
1か月 パフォーマンス:
+14.97%
6か月 パフォーマンス:
-65.27%
1年 パフォーマンス:
-91.37%
1日の値動き範囲:
$0.5081
$0.54
1週間の範囲:
$0.444
$0.54
52週間の値動き範囲:
$0.404
$6.3786
Alx Oncology Holdings Inc Stock (ALXO) Company Profile
名前
Alx Oncology Holdings Inc
セクター
電話
650-466-7125
住所
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO
ALXO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALXO
Alx Oncology Holdings Inc
|
0.5262 | 28.86M | 0 | -151.16M | -130.08M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Alx Oncology Holdings Inc Stock (ALXO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-06 | アップグレード | Jefferies | Hold → Buy |
| 2024-12-19 | ダウングレード | Jefferies | Buy → Hold |
| 2024-03-08 | ダウングレード | Stifel | Buy → Hold |
| 2023-12-08 | アップグレード | Jefferies | Hold → Buy |
| 2021-12-22 | ダウングレード | Jefferies | Buy → Hold |
| 2021-09-30 | 開始されました | Stifel | Buy |
| 2021-05-05 | 再開されました | Credit Suisse | Outperform |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-04-06 | 開始されました | UBS | Buy |
| 2021-02-10 | 開始されました | H.C. Wainwright | Buy |
| 2020-08-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-08-11 | 開始されました | Credit Suisse | Outperform |
| 2020-08-11 | 開始されました | Jefferies | Buy |
| 2020-08-11 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Alx Oncology Holdings Inc (ALXO) 最新ニュース
Why ALX Oncology Holdings Inc. stock attracts strong analyst attentionFree Premium Stock Market Reports - Metal.it
Why did ALXO's EPS remain flat throughout 2024? - AInvest
Is ALX Oncology Holdings Inc. stock overhyped or has real potentialFree Stock Chart Pattern Guide - jammulinksnews.com
Alx Oncology Faces Delisting Threat: Nasdaq Compliance Deadline Looms - TipRanks
How ALX Oncology Holdings Inc. stock performs during market volatilityVerified Chart Patterns - Newser
What analysts say about ALX Oncology Holdings Inc. stockTriple returns potential - Autocar Professional
ALX Oncology Holdings Inc. Stock Analysis and ForecastPhenomenal returns - Autocar Professional
What drives ALX Oncology Holdings Inc. stock priceOverwhelming profit margins - jammulinksnews.com
Is ALX Oncology Holdings Inc. a good long term investmentMarket-beating returns - jammulinksnews.com
Will ALX Oncology Holdings Inc. stock benefit from interest rate changesConsistent Win Signals - Newser
What makes ALX Oncology Holdings Inc. stock price move sharplyRisk Adjusted Stock Signals - Newser
ALX Oncology (NASDAQ:ALXO) Trading Down 3.5% – What’s Next? - Defense World
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Given Average Rating of “Moderate Buy” by Analysts - Defense World
ALX Oncology Confirms Directors at Annual Meeting - TipRanks
ALX Oncology reports annual meeting results By Investing.com - Investing.com Nigeria
ALX Oncology reports annual meeting results - Investing.com
Cantor Fitzgerald Weighs in on ALX Oncology FY2026 Earnings - Defense World
ALX Oncology (NASDAQ:ALXO) Downgraded to “Sell” Rating by Wall Street Zen - Defense World
Nuveen Asset Management LLC Has $275,000 Holdings in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares Acquired by Two Sigma Investments LP - Defense World
Bank of America Corp DE Grows Position in ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
ALX Oncology Holdings Inc. (NASDAQ:ALXO) Shares Acquired by Deutsche Bank AG - Defense World
Northern Trust Corp Acquires 23,324 Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO) - Defense World
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference - GlobeNewswire
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference | ALXO Stock News - GuruFocus
ALX Oncology Management to Showcase Novel Cancer Treatment Advances at Major Jefferies Healthcare Conference - Stock Titan
Alx Oncology Holdings Inc (ALXO) 財務データ
収益
当期純利益
現金流量
EPS
0.97%
0.22%
大文字化:
|
ボリューム (24 時間):